Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10908969 | Leukemia Research | 2012 | 5 Pages |
Abstract
We evaluated the efficacy and toxicity of retreatment with purine analogs (PA) in 62 patients with relapsed chronic lymphocytic leukemia. Median OS and PFS after retreatment were 60 and 26 months, respectively. By multivariate analysis, minimal residual disease status, ZAP-70 expression and age had independent predictive power in terms of OS. Toxicity was mainly neutropenia (21%) and infections (39%). Second malignancies were observed in 10 (16%) patients. Our results outline that retreatment with PA is remarkably effective in patients with relapsed CLL, but with a significant toxicity.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ivan Dlouhy, Gabriela Ghita, Tycho Baumann, Eva Gine, Neus Villamor, Maria Rozman, Alejandra Martinez-Trillos, Armando Lopez-Guillermo, Julio Delgado,